Viewing Study NCT02147951


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2026-01-04 @ 3:08 AM
Study NCT ID: NCT02147951
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2016-03-01
First Post: 2014-05-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module